Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 2
1980 1
1981 1
1982 1
1983 3
1984 2
1985 1
1986 2
1988 5
1989 5
1990 5
1991 5
1992 6
1993 14
1994 7
1995 15
1996 19
1997 23
1998 34
1999 25
2000 39
2001 37
2002 34
2003 47
2004 39
2005 58
2006 50
2007 50
2008 76
2009 60
2010 88
2011 89
2012 80
2013 85
2014 76
2015 92
2016 112
2017 123
2018 113
2019 105
2020 71
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

1,557 results
Results by year
Filters applied: . Clear all
Page 1
Genetics of diabetes mellitus and diabetes complications.
Cole JB, Florez JC. Cole JB, et al. Nat Rev Nephrol. 2020 Jul;16(7):377-390. doi: 10.1038/s41581-020-0278-5. Epub 2020 May 12. Nat Rev Nephrol. 2020. PMID: 32398868 Review.
Devastating macrovascular complications (cardiovascular disease) and microvascular complications (such as diabetic kidney disease, diabetic retinopathy and neuropathy) lead to increased mortality, blindness, kidney failure and an overall …
Devastating macrovascular complications (cardiovascular disease) and microvascular complications (such as …
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.
Targher G, Lonardo A, Byrne CD. Targher G, et al. Nat Rev Endocrinol. 2018 Feb;14(2):99-114. doi: 10.1038/nrendo.2017.173. Epub 2017 Dec 29. Nat Rev Endocrinol. 2018. PMID: 29286050 Review.
The coexistence of NAFLD and diabetes mellitus increases the risk of developing not only the more severe forms of NAFLD but also chronic vascular complications of diabetes mellitus. Indeed, substantial evidence links NAFLD with an increas …
The coexistence of NAFLD and diabetes mellitus increases the risk of developing not only the more severe forms of NAFLD …
Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications.
Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW. Dal Canto E, et al. Eur J Prev Cardiol. 2019 Dec;26(2_suppl):25-32. doi: 10.1177/2047487319878371. Epub 2019 Nov 13. Eur J Prev Cardiol. 2019. PMID: 31722562 Review.
Cardiovascular disease represents the principal cause of death and morbidity among people with diabetes, especially in those with type 2 diabetes mellitus. ...Given the substantial clinical impact of diabetes as a cardiovascular
Cardiovascular disease represents the principal cause of death and morbidity among people with diabetes, especially in
Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
Katsiki N, Anagnostis P, Kotsa K, Goulis DG, Mikhailidis DP. Katsiki N, et al. Curr Pharm Des. 2019;25(18):2051-2059. doi: 10.2174/1381612825666190708192134. Curr Pharm Des. 2019. PMID: 31298151 Review.
BACKGROUND: Obesity frequently co-exists with type 2 diabetes mellitus (T2DM), leading to the socalled "diabesity epidemic". ...Links between NAFLD and diabetic microvascular complications have also been reported but data are still limited. ...
BACKGROUND: Obesity frequently co-exists with type 2 diabetes mellitus (T2DM), leading to the socalled "diabesity epidemic". . …
Cardiovascular disease in diabetes mellitus: risk factors and medical therapy.
Szuszkiewicz-Garcia MM, Davidson JA. Szuszkiewicz-Garcia MM, et al. Endocrinol Metab Clin North Am. 2014 Mar;43(1):25-40. doi: 10.1016/j.ecl.2013.09.001. Epub 2013 Dec 8. Endocrinol Metab Clin North Am. 2014. PMID: 24582090 Review.
Cardiovascular disease is a serious complication of diabetes mellitus. ...This review summarizes the current state of knowledge and discusses areas of uncertainty in the care of patients with diabetes who are at risk for cardiov
Cardiovascular disease is a serious complication of diabetes mellitus. ...This review summarizes the curr
Microvascular Complications of Type 2 Diabetes Mellitus.
Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Faselis C, et al. Curr Vasc Pharmacol. 2020;18(2):117-124. doi: 10.2174/1570161117666190502103733. Curr Vasc Pharmacol. 2020. PMID: 31057114 Review.
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic, non communicable, multisystem disease that has reached epidemic proportions. ...METHODS: A comprehensive review of the literature was performed to identify data from clinical studies for the prevalence …
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic, non communicable, multisystem disease that has reached epidem …
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors.
Heerspink HJL, Kosiborod M, Inzucchi SE, Cherney DZI. Heerspink HJL, et al. Kidney Int. 2018 Jul;94(1):26-39. doi: 10.1016/j.kint.2017.12.027. Epub 2018 May 5. Kidney Int. 2018. PMID: 29735306 Review.
Over the past two years, our understanding of anti-hyperglycemic medications used to treat patients with type 2 diabetes (T2D) has fundamentally changed. Before the EMPA-REG OUTCOME trial, agents used to lower blood glucose were felt to prevent or delay the development of …
Over the past two years, our understanding of anti-hyperglycemic medications used to treat patients with type 2 diabetes (T2D) has fu …
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Nathan DM, et al. N Engl J Med. 2005 Dec 22;353(25):2643-53. doi: 10.1056/NEJMoa052187. N Engl J Med. 2005. PMID: 16371630 Free PMC article. Clinical Trial.
BACKGROUND: Intensive diabetes therapy aimed at achieving near normoglycemia reduces the risk of microvascular and neurologic complications of type 1 diabetes. ...CONCLUSIONS: Intensive diabetes therapy has long-term beneficial effects on …
BACKGROUND: Intensive diabetes therapy aimed at achieving near normoglycemia reduces the risk of microvascular and neur …
Glycemic control and complications in type 2 diabetes mellitus.
Stolar M. Stolar M. Am J Med. 2010 Mar;123(3 Suppl):S3-11. doi: 10.1016/j.amjmed.2009.12.004. Am J Med. 2010. PMID: 20206730 Review.
Current guidelines for treating patients with type 2 diabetes mellitus are based on glycemic standards derived from epidemiologic data; however, the course of the disease, from prediabetes to end-stage complications, is not the same in all patients. .. …
Current guidelines for treating patients with type 2 diabetes mellitus are based on glycemic standards derived from epidemiolo …
Sex differences in micro- and macro-vascular complications of diabetes mellitus.
Maric-Bilkan C. Maric-Bilkan C. Clin Sci (Lond). 2017 May 1;131(9):833-846. doi: 10.1042/CS20160998. Clin Sci (Lond). 2017. PMID: 28424377 Review.
In general, men appear to be at a higher risk for diabetic microvascular complications, while the consequences of macrovascular complications may be greater in women. ...Thus, the presence of diabetes confers greater risk for vascular …
In general, men appear to be at a higher risk for diabetic microvascular complications, while the consequences of macro …
1,557 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page